Multiple sclerosis (MS) is a common autoimmune disease that targets myelin in the central
nervous system (CNS). Multiple genome-wide association studies (GWAS) over the past 10 …

Multiple sclerosis (MS) is a prevalent inflammatory disease of the central nervous system
that often leads to disability in young adults. Treatment options are limited and often only …

Background Multiple sclerosis is an inflammatory demyelinating disease of the central
nervous system and is the most common cause of neurologic disability in young adults …

Multiple sclerosis (MS) is a disease with profound heterogeneity in clinical course,
neuroradiological appearance of the lesions, involvement of susceptibility gene loci, and …

Microarray analysis of multiple sclerosis (MS) lesions obtained at autopsy revealed
increased transcripts of genes encoding inflammatory cytokines, particularly interleukin-6 …

Background Multiple sclerosis has a clinically significant heritable component. We
conducted a genomewide association study to identify alleles associated with the risk of …

Multiple sclerosis is a demyelinating disease, characterized by inflammation in the brain and
spinal cord, possibly due to autoimmunity. Large-scale sequencing of cDNA libraries …

Multiple sclerosis (MS) is probably aetiologically heterogeneous. Systematic genetic
epidemiological and molecular genetic studies have provided important insights. Both …

Multiple sclerosis: a two-stage disease | Nature Immunology Skip to main content Thank you
for visiting nature.com. You are using a browser version with limited support for CSS. To obtain …

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS)
characterized by plaques of infiltrating CD4+ and CD8+ T cells. Studies of MS and …